NUE-20798

N/A

Report date: 2023/03/05 18:10:22
NME

Base Information

Drug NameNUE-20798
Drug Alias NameNUE-20798
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain-containing protein 1 inhibitors
TargetsBromodomain-containing protein 1
Therapy Area/IndicationsDermatitis, Atopic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNuevolution AB(publ)
China Registration ClassN/A

Develop Information

Active CompaniesNuevolution AB(publ)
Inactive CompaniesN/A
Active IndicationsDermatitis, Atopic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A